What top creators are saying about Spruce Biosciences Inc.(SPRB)
Rare disease drug company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Spruce Biosciences Inc. in the last 30 days yet.
Top creators covering Spruce Biosciences Inc. (SPRB)
The 1 sources with the most insights about Spruce Biosciences Inc. on Kazuha.
Latest insights about Spruce Biosciences Inc. (SPRB)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Wednesday, October 22, 2025
The speaker is bullish, viewing it as a long-term investment with a drug that 'works really well' and is likely to receive FDA approval, potentially leading to a 5x return.
Wednesday, October 22, 2025
The speaker is bullish, viewing it as a long-term investment with a drug that 'works really well' and is likely to receive FDA approval, potentially leading to a 5x return.
Discussed alongside Spruce Biosciences Inc. (SPRB)
Other assets that creators frequently mention in the same content as Spruce Biosciences Inc..
Frequently asked
Which podcasters and creators cover Spruce Biosciences Inc. (SPRB) the most?
The most active sources covering Spruce Biosciences Inc. (SPRB) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Spruce Biosciences Inc. (SPRB) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Spruce Biosciences Inc. (SPRB) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Spruce Biosciences Inc. (SPRB)?
Creators covering Spruce Biosciences Inc. (SPRB) most frequently also discuss BYND, AMC, NEGG, QBTS, RGTI. See the "Discussed alongside" section above for full asset pages.